Skip to main content
SpringerLink
Log in
Book cover

Management of Lung Cancer in Older People pp 141–150Cite as

Is There a Role for Neoadjuvant Chemotherapy in Older Patients?

  • Chapter
  • First Online:

  • 1080 Accesses

Abstract

No clinical trial specifically assesses the value of neoadjuvant chemotherapy directed to elderly population. Elderly patients with cancer often present with medical and physiological challenges, and it is crucial to carefully evaluate functional and psychological status in order to decide on the best approach. A multidisciplinary assessment is essential in the selection of elderly patients who may benefit from a more aggressive multimodality treatment which is at present reserved for younger patients.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.

    Article  PubMed  Google Scholar 

  2. Nesbitt JC, Putnam Jr JB, Walsh GL, et al. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg. 1995;60:466–72.

    Article  PubMed  CAS  Google Scholar 

  3. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation (LACE): a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26:3552–9.

    Article  PubMed  Google Scholar 

  4. Crino L, Weder W, Meerbeeck JV, Felip E. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Supplement 5):v103–15.

    Article  PubMed  Google Scholar 

  5. Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the Surveillance, Epidemiology, and End Results Database. J Clin Oncol. 2007;25:5570–7.

    Article  PubMed  Google Scholar 

  6. Roth JA, Fosella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer. J Natl Cancer Inst. 1994;86:673–80.

    Article  PubMed  CAS  Google Scholar 

  7. Roth JA, Atkinson EN, Fossella T, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer. 1998;21:1–6.

    Article  PubMed  CAS  Google Scholar 

  8. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153–8.

    Article  PubMed  CAS  Google Scholar 

  9. Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer. 1999;26:7–14.

    Article  PubMed  CAS  Google Scholar 

  10. Depierre A, Milleron B, Moro-Sibilot D, et al. Pre-operative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIA non-small cell lung cancer. J Clin Oncol. 2002;20:247–53.

    Article  PubMed  Google Scholar 

  11. Depierre A, Westeel V, Milleron B, et al. 5 year results of the French randomized study comparing preoperative chemotherapy followed by surgery and primary surgery in resectable stage I (except T1N0), II and IIIA non-small cell lung cancer. Lung Cancer. 2003;41 Suppl 2:S62. Journal article/abstract.

    Article  Google Scholar 

  12. Westeel V, Milleron BJ, Quoix EA, et al, on behalf of the Intergroupe Francophone de Cancerologie Thoracique. Long-term results of the French randomized trial comparing neoadjuvant chemotherapy followed by surgery versus surgery alone in resectable non-small cell lung cancer (Abstract 7003). J Clin Oncol. 2010;28 (15 May 20 Suppl).

    Google Scholar 

  13. Pisters KMW, Vallieres E, Crowley JJ, et al. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol. 2010;28:1843–9.

    Article  PubMed  CAS  Google Scholar 

  14. Gilligan D, Nicolson M, Smith I, et al. On behalf of the trial collaborators. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Lancet. 2007;369:1929–37.

    Article  PubMed  CAS  Google Scholar 

  15. Berz D, Birbbaum A, Dipetrillo TA, et al. Neoadjuvant carboplatin and weekly paclitaxel in stage Ib-III non-small cell lung cancer (NSCLC): a Brown University Oncology Group (BrUOG) phase II study. J Clin Oncol, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition).Vol 26, No 15S (May 20 Supplement), 2008: 18502.

    Google Scholar 

  16. Westeel V, Milleron B, Quoix E, et al. Results of the IFCT 0002 phase III study comparing a preoperative and a perioperative chemotherapy (CT) with two different CT regimens in resectable non-small cell lung cancer (NSCLC). J Clin Oncol, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition).Vol 27, No 15S (May 20 Supplement), 2009: 7530.

    Google Scholar 

  17. Felip E, Rosell R, Maestre JA, et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small cell lung cancer. J Clin Oncol. 2010;28:3138–45.

    Article  PubMed  CAS  Google Scholar 

  18. Scagliotti GV, Pastorino U, Vansteenkiste JF, et al. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small cell lung cancer. J Clin Oncol. 2012;30:172–8.

    Article  PubMed  CAS  Google Scholar 

  19. Berghmans T, Paesmans M, Meert AP, et al. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature. Lung Cancer. 2005;49:13–23.

    Article  PubMed  CAS  Google Scholar 

  20. Burdett S, Stewart L, Rydzewska L, et al. A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer. J Thorac Oncol. 2006;1:611–21.

    Article  PubMed  Google Scholar 

  21. Burdett S, Rydzewska LH, Tierney JF, Pignon JP. Pre-operative chemotherapy improves survival and reduces recurrence in operable non-small cell lung cancer: preliminary results of a systematic review and meta-analysis of individual patient data from 13 randomised trials. J Thor Oncol. 2011;6(Suppl 2):374–375.

    Google Scholar 

  22. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061–7.

    Article  PubMed  CAS  Google Scholar 

  23. Iacobelli S, Irtelli L, Martino MT. Neoadjuvant chemotherapy for surgically staged IIIAN2 Non-Small Cell Lung Cancer (NSCLC) in the elderly. Proc Am Soc Clin Oncol 20: 2001 (abstr 2725).

    Google Scholar 

  24. D´Angelillo RM, Trodella L, Ramella S, et al. Neoadjuvant chemoradiotherapy followed by surgery in elderly patients with locally advanced non-small cell lung cancer: analysis of feasibility, toxicity and factors predicting surgical resection and survival. J Clin Oncol 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement), 2004: 7167.

    Google Scholar 

  25. Janssen-Heijnen MLG, Schipper RM, Razenberg PPA, et al. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 1998;21:105–13.

    Article  PubMed  CAS  Google Scholar 

  26. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374:1196–208.

    Article  PubMed  Google Scholar 

  27. Tammemagi CM, Nulurd-Dudos C, Simoff L, et al. Impact of comorbidity on lung cancer survival. Int J Cancer. 2003;103:792–802.

    Article  PubMed  CAS  Google Scholar 

  28. Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin. 2010;60:120–32.

    Article  PubMed  Google Scholar 

  29. Davidoff AJ, Tang M, Seal B, et al. Chemotherapy and survival benefit in elderly patients with advanced non-small cell lung cancer. J Clin Oncol. 2010;28:2191–7.

    Article  PubMed  Google Scholar 

  30. Gridelli C, Maione P, Rossi A, et al. Treatment of advanced non-small cell lung cancer in the elderly. Lung Cancer. 2009;66:282–6.

    Article  PubMed  Google Scholar 

  31. Elderly Lung Cancer Vinorelbine Italian Study (ELVIS) Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst. 1999;91:66–72.

    Article  Google Scholar 

  32. Gridelli C, Cigolari S, Gallo C, et al. Activity and toxicity of gemcitabine and gemcitabine - vinorelbine in advanced non-small-cell lung cancer elderly patients. Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial. Lung Cancer. 2001;31:277–84.

    Article  PubMed  CAS  Google Scholar 

  33. Fidias P, Supko JG, Martins R, et al. A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer. Clin Cancer Res. 2001;7:3942–9.

    PubMed  CAS  Google Scholar 

  34. Kudoh S, Takeda K, Nakagawa K, et al. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904). J Clin Oncol. 2006;24:3657–63.

    Article  PubMed  CAS  Google Scholar 

  35. Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst. 2003;95:362–72.

    Article  PubMed  CAS  Google Scholar 

  36. Feliu J, Martin G, Madronal C, et al. Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2003;52:247–52.

    Article  PubMed  CAS  Google Scholar 

  37. Ohe Y, Niho S, Kakinuma R, et al. A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients. Ann Oncol. 2004;15:45–50.

    Article  PubMed  CAS  Google Scholar 

  38. Gridelli C, Maione P, Illiano A, et al. Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies. J Clin Oncol. 2007;25:4663–9.

    Article  PubMed  CAS  Google Scholar 

  39. Crino L, Cappuzzo F, Zatloukal P, et al. Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study. J Clin Oncol. 2008;26:4253–60.

    Article  PubMed  CAS  Google Scholar 

  40. Gridelli C, Morabito A, Gebbia V, et al. Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomised phase II trials. Lung Cancer 67: 86–92.

    Google Scholar 

  41. Gridelli C, Rossi A, Mongillo F, et al. A randomized phase II study of sorafenib/gemcitabine or sorafenib/erlotinib for advanced non-small-cell lung cancer in elderly patients or patients with a performance status of 2: treatment rationale and protocol dynamics. Clin Lung Cancer. 2007;8:396–8.

    Article  PubMed  Google Scholar 

  42. Ramalingam S, Perry MC, La Rocca RV, et al. Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced non-small cell lung cancer. Cancer. 2008;113:542–6.

    Article  PubMed  CAS  Google Scholar 

  43. Quoix E, Zalcman G, Oster JP, et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet. 2011;378:1079–88.

    Article  PubMed  CAS  Google Scholar 

  44. Azzoli CG, Temin S, Aliff T, et al. Focused update of 2009 American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol. 2011;29:3825–31.

    Article  PubMed  Google Scholar 

  45. Felip E, Gridelli C, Baas P, et al. Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010. Ann Oncol. 2011;22:1507–19.

    Article  PubMed  CAS  Google Scholar 

  46. Rivera MP, Detterbeck F, Socinski M, et al. Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer. Chest. 2009;135:1588–95.

    Article  PubMed  Google Scholar 

  47. Rivera C, Jougon J, Dahan M, et al. Are postoperative consequences of neoadjuvant chemotherapy for non-small cell lung cancer more severe in elderly patients? Lung Cancer. 2012;76(2):216–21.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oncology Department, Vall d’Hebron University Hospital, Barcelona, Spain

    Alejandro Navarro MD & Enriqueta Felip MD, PhD

Authors
  1. Alejandro Navarro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Enriqueta Felip MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Enriqueta Felip MD, PhD .

Editor information

Editors and Affiliations

  1. , Department of Oncology/Hematology, S.G. Moscati Hospital, Contrada Amoretta, Avellino, 83100, Italy

    Cesare Gridelli

  2. St Helens Teaching Hospital, University of Liverpool, Marshalls Cross Road, St Helens, WA9 3DA, United Kingdom

    Riccardo A Audisio

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Navarro, A., Felip, E. (2013). Is There a Role for Neoadjuvant Chemotherapy in Older Patients?. In: Gridelli, C., Audisio, R. (eds) Management of Lung Cancer in Older People. Springer, London. https://doi.org/10.1007/978-0-85729-793-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-793-8_10

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-792-1

  • Online ISBN: 978-0-85729-793-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation